Despite the dissipated interest by most media outlets in the US, the outbreak of Ebola in West Africa continues. The CDC and WHO have updated Ebola case counts for the West African countries impacted most by the outbreak. The number of deaths now exceeds 8,000.
A clinical trial testing the safety of an Ebola vaccine has had to undergo a change in dose. The trial in Geneva, is testing a vaccine made by Merck-NewLink, and was halted in early December.
The clinical trial of an Ebola vaccine developed by Merck and NewLink resumed on Monday at a lower dose after a pause to assess complaints of joint pains in some volunteers, the University of Geneva hospital said.
